PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2012 | 7 | 2 | 258-261
Article title

Neutrophil to lymphocyte count ratio as a biomarker of bacterial infections

Content
Title variants
Languages of publication
EN
Abstracts
EN
The implementation of new markers of bacterial infection into clinical practice is hindered by their costs. We assessed the potential use of the neutrophil to lymphocyte count ratio (NLCR) to discriminate between bacterial and viral infections. NLCR was evaluated in 45 patients with bacterial infections: 24 patients with viral infections and 18 healthy adults. The medians of NLCR were 11.73 in bacterial infections, 2.86 in viral infections and 1.86 in controls. The NLCR cut-off value of 6.2 exhibited a sensitivity value of 0.91 and a specificity value of 0.96 for bacterial infection. These results suggest a diagnostic potential for NLCR.
Publisher

Journal
Year
Volume
7
Issue
2
Pages
258-261
Physical description
Dates
published
1 - 4 - 2012
online
3 - 2 - 2012
Contributors
author
  • Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague and University Hospital Bulovka, CZ-180 81, Prague, Czech Republic
author
  • Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague and University Hospital Bulovka, CZ-180 81, Prague, Czech Republic
  • Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University in Prague, CZ-120 00, Prague, Czech Republic
author
  • Department of Infectious and Tropical Diseases, First Faculty of Medicine, Charles University in Prague and University Hospital Bulovka, CZ-180 81, Prague, Czech Republic, pavel.chalupa@lf1.cuni.cz
References
  • [1] Adams NG. Diagnostic use of C-reactive protein in bacteraemic emergency department patients. Emerg Med Australan 2005; 17: 371–375 http://dx.doi.org/10.1111/j.1742-6723.2005.00759.x[Crossref]
  • [2] Ho KM, Lipman J. An update on C-reactive protein for intensivists. Anaesth Intensive Care 2009; 37: 234–241 [PubMed]
  • [3] Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 34: 515–518 http://dx.doi.org/10.1016/0140-6736(93)90277-N[Crossref]
  • [4] Russell JA. Management of sepsis. N Engl J Med 2006; 355: 1699–1713. Erratum in: N Engl J Med 2006; 355: 2267 http://dx.doi.org/10.1056/NEJMra043632[Crossref]
  • [5] Chalupa P, Beran O, Herwald H, Kaspříková N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011; 39: 411–417 http://dx.doi.org/10.1007/s15010-011-0126-4[WoS][Crossref]
  • [6] Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill [Article in English and Slovak]. Bratisl Med J 2001; 102: 5–14 [WoS]
  • [7] de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care 2010; 14: R192 http://dx.doi.org/10.1186/cc9309[WoS][Crossref]
  • [8] Mills GD, Lala HM, Oehley MR, Craig AB, Barratt K, Hood D, Thornley CN, Nesdale A, Manikkam NE, Reeve P. Elevated procalcitonin as a diagnostic marker in meningococcal disease. Eur J Clin Microbiol Infect Dis 2006; 25: 501–509 http://dx.doi.org/10.1007/s10096-006-0179-y[Crossref]
  • [9] Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458–461 http://dx.doi.org/10.1097/00003246-200002000-00028[Crossref]
  • [10] Shehabi Y, Seppelt I. Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 2008; 12: 211 http://dx.doi.org/10.1186/cc6860[Crossref]
  • [11] Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol 2004; 57: 950–955 http://dx.doi.org/10.1136/jcp.2004.017335[Crossref]
  • [12] Holub M, Kluckova Z, Beneda B, Hobstova J, Huzicka I, Prazak J, Lobovska A. Changes in lymphocyte subpopulations and CD3+/DR+ expression in sepsis. Clin Microbiol Infect 2000; 6: 657–660 http://dx.doi.org/10.1046/j.1469-0691.2000.00175.x[Crossref]
  • [13] Gorbach SL. Neutropenic enterocolitis. Clin Infect Dis 1998; 27: 700–701 http://dx.doi.org/10.1086/514945[Crossref]
  • [14] Batlle M, Vall-Llovera F, Bechini J, Camps I, Marcos P, Vives S, Oriol A, Ribera JM. Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases [Article in Spanish]. Med Clin (Barc) 2007; 129: 660–663 http://dx.doi.org/10.1157/13112098[Crossref]
  • [15] Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990; 89: 291–296 http://dx.doi.org/10.1016/0002-9343(90)90340-J
  • [16] Okada H, Kobune F, Sato TA, Kohama T, Takeuchi Y, Abe T, Takayama N, Tsuchiya T, Tashiro M. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 2000; 145: 905–920 http://dx.doi.org/10.1007/s007050050683[Crossref]
  • [17] Ramaekers LH, Theunissen PM, Went K. Acute lymphopenia, stress, and plasma cortisol. Arch Dis Child 1975; 50: 555–558 http://dx.doi.org/10.1136/adc.50.7.555[Crossref]
  • [18] Ohsawa M, Nakamura M, Pan LH, Shizuka T, Nakagawa J, Ishida H, Ouchi M, Shiroto T, Hotta K, Sawai T, Hiramori K. Post-operative constrictive pericarditis complicated with lymphocytopenia and hypoglobulinemia. Intern Med 2004; 43: 811–815 http://dx.doi.org/10.2169/internalmedicine.43.811[Crossref]
  • [19] Cardeñosa N, Romero M, Quesada M, Oviedo M, Carmona G, Codina G, Jansà JM, Domínguez A. Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease? Vaccine 2009; 27: 3489–3491 http://dx.doi.org/10.1016/j.vaccine.2009.01.046[WoS][Crossref]
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-012-0002-3
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.